Lilly lowers the price of Zepbound (tirzepatide) single-dose vials

Eli Lilly

1 December 2025 - Eli Lilly announced Zepbound (tirzepatide) single dose vials will now be available at lower prices on LillyDirect, the company’s digital health care platform. 

This update builds on Lilly’s on-going efforts to lower out of pocket costs for people living with obesity in the US.

Read Eli Lilly press release

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Pricing